The Treatment of Autosomal Dominant Polycystic Kidney Disease.

Journal: Deutsches Arzteblatt international
Published Date:

Abstract

BACKGROUND: About one in 2000 persons in Europe suffers from autosomal dominant polycystic kidney disease (ADPKD). The treatment of this disease up to the present has been limited to the management of complications.

Authors

  • Wolfgang E Kühn
    Department of Palliative Medicine, University Hospital Munich, Campus Grosshadern, Department of Palliative Medicine, University Hospital Cologne, Department of Palliative Medicine, University Hospital Bonn, Department of Palliative Medicine, University Medical Center Göttingen.
  • Gerd Walz